Total Funding
93
68
Total FundingSeries B raised
Growth Score 93 in past quarter
5 pts
Heat Score 68 in past quarter
45 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7021
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
- Ryan Corcoran: Co-Founder
- Eric Murphy: Co-Founder and CEO
About the Company
Sidewinder Therapeutics develops bispecific antibody-drug conjugates (ADCs) aimed at treating solid tumors. Their mission is to create life-saving therapies through precision therapeutics.
